NCT03424473

Brief Summary

Physicians interested in requesting a single patient IND should contact Seattle Genetics' Medical Information (medinfo@seagen.com).

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 7, 2018

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

First QC Date

January 31, 2018

Last Update Submit

February 21, 2020

Interventions

TucatinibDRUG

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast NeoplasmsBrain NeoplasmsNeoplasms by SiteNeoplasmsBreast Diseases

Interventions

tucatinib

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2018

First Posted

February 7, 2018

Last Updated

February 25, 2020

Record last verified: 2020-02